<DOC>
	<DOCNO>NCT00426972</DOCNO>
	<brief_summary>This trial ass effect Zesteem ( estradiol ) heal split thickness skin graft donor sit patient age 18-85 year .</brief_summary>
	<brief_title>Trial Zesteem ( Estradiol ) Healing Split Thickness Skin Graft Donor Sites</brief_title>
	<detailed_description />
	<mesh_term>Varicose Ulcer</mesh_term>
	<mesh_term>Estradiol</mesh_term>
	<mesh_term>Polyestradiol phosphate</mesh_term>
	<mesh_term>Estradiol 3-benzoate</mesh_term>
	<mesh_term>Estradiol 17 beta-cypionate</mesh_term>
	<mesh_term>Estradiol valerate</mesh_term>
	<criteria>Patients age 1885 year provide write informed consent . Patients require skin grafting due burn , trauma chronic venous ulcer , donor site expect 20 200 cm2 nonarticulated area . Female patient child bear potential use method ( ) contraception acceptable Investigator agree least screening visit one month administration final study dose . Patients burn involve 15 % total body area . Patients sepsis , haemodynamic instability require pressor support positive blood microbiology culture within 48h surgery . Patients inhalation injury require artificial respiratory assistance . Patients require skin graft follow removal suspicious skin lesion . Patients receive treatment systemic steroid 30 day prior surgery . Patients receive immunosuppressive drug , radiation chemotherapy three month prior surgery . Patients history malignancy previous three year . Patients uncontrolled diabetes diabetic ulcer . Patients diseases condition could , opinion Investigator , interfere assessment safety , tolerability efficacy . Patients previously skin graft harvest area study . Patients skin disorder chronic currently active Investigator considers adversely affect heal acute wound involve area examine trial . Patients history clinically significant hypersensitivity drug surgical dressing use trial . Patients take , take , investigational drug within 3 month prior screen visit . Patients undergoing investigation change management exist medical condition . Patients become pregnant include Day 0 lactating . In opinion Investigator , patient likely complete trial whatever reason .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>August 2009</verification_date>
</DOC>